Golestan University of Medical Sciences Repository

The use of immunoglobulin therapy in primary immunodeficiency diseases

Azizi, G. and Abolhassani, H. and Asgardoon, M.H. and Rahnavard, J. and Dizaji, M.Z. and Yazdani, R. and Mohammadi, J. and Aghamohammadi, A. (2016) The use of immunoglobulin therapy in primary immunodeficiency diseases. Endocrine, Metabolic and Immune Disorders - Drug Targets, 16 (2). pp. 80-88.

Full text not available from this repository.

Abstract

Immunoglobulin therapy represents a lifesaving intervention for many patients with primary immunodeficiency (PID). Antibody defects represent approximately half of the well-known PIDs requiring immunoglobulin replacement therapy. Following immunoglobulin therapy in PID patients, protection against serious upper and lower respiratory tract infections and pulmonary function improves which leads to an increase in the quality of life of these patients. Successful treatment of PID patients depends on the type of immunodeficiency, regular monitoring of the patient, comorbidities of the patient, and the availability of the products. © 2016 Bentham Science Publishers.

Item Type: Article
Additional Information: cited By 3
Subjects: مقالات نمایه شده محققین دانشگاه در سایت ,Web of Science ,Scopus
Divisions: UNSPECIFIED
Depositing User: GOUMS
Date Deposited: 13 Jun 2017 06:09
Last Modified: 13 Jun 2017 06:09
URI: http://eprints.goums.ac.ir/id/eprint/4944

Actions (login required)

View Item View Item